David S. Weiss, Ph.D.

Emory University, Atlanta, GA 
Antibiotic resistance
"David Weiss"


Sign in to add mentor
Arturo Zychlinsky grad student 2004 NYU (Microtree)
Stanley Falkow post-doc 2009 Stanford
Denise M. Monack post-doc 2009 Stanford


Sign in to add trainee
Hannah Ratner grad student 2013-2019 Emory (Chemistry Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ratner HK, Weiss DS. (2021) crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense. Rna Biology. 1-14
Shohat H, Illouz-Eliaz N, Kanno Y, et al. (2020) The tomato DELLA protein PROCERA promotes ABA responses in guard cells by upregulating an ABA transporter. Plant Physiology
Ratner HK, Weiss DS. (2020) CRISPR-Cas systems can functionally complement each other in DNA defense while providing target flexibility. Journal of Bacteriology
Ratner HK, Escalera-Maurer A, Le Rhun A, et al. (2019) Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence. Molecular Cell
Ratner HK, Sampson TR, Weiss DS. (2016) Overview of CRISPR-Cas9 Biology. Cold Spring Harbor Protocols. 2016: pdb.top088849
Band VI, Crispell EK, Napier BA, et al. (2016) Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nature Microbiology. 1: 16053
Chin CY, Gregg KA, Napier BA, et al. (2015) A PmrB-regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy
Price AA, Sampson TR, Ratner HK, et al. (2015) Cas9-mediated targeting of viral RNA in eukaryotic cells. Proceedings of the National Academy of Sciences of the United States of America. 112: 6164-9
Ratner HK, Sampson TR, Weiss DS. (2015) I can see CRISPR now, even when phage are gone: a view on alternative CRISPR-Cas functions from the prokaryotic envelope. Current Opinion in Infectious Diseases. 28: 267-74
Napier RJ, Norris BA, Swimm A, et al. (2015) Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. Plos Pathogens. 11: e1004770
See more...